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OBJECTIVE—Reactive oxygen species (ROS) is one of most
important factors in impaired metabolism secretion coupling in
pancreatic -cells. We recently reported that elevated ROS
production and impaired ATP production at high glucose in
diabetic Goto-Kakizaki (GK) rat islets are effectively ameliorated
by Src inhibition, suggesting that Src activity is upregulated. In
the present study, we investigated whether the glucagon-like
peptide-1 signal regulates Src activity and ameliorates endoge-
nous ROS production and ATP production in GK islets using
exendin-4.
RESEARCH DESIGN AND METHODS—Isolated islets from
GK and control Wistar rats were used for immunoblotting
analyses and measurements of ROS production and ATP content.
Src activity was examined by immunoprecipitation of islet ly-
sates followed by immunoblotting. ROS production was mea-
sured with a ﬂuorescent probe using dispersed islet cells.
RESULTS—Exendin-4 signiﬁcantly decreased phosphorylation
of Src Tyr416, which indicates Src activation, in GK islets under
16.7 mmol/l glucose exposure. Glucose-induced ROS production
(16.7 mmol/l) in GK islet cells was signiﬁcantly decreased by
coexposure of exendin-4 as well as PP2, a Src inhibitor. The Src
kinase–negative mutant expression in GK islets signiﬁcantly
decreased ROS production induced by high glucose. Exendin-4,
as well as PP2, signiﬁcantly increased impaired ATP elevation by
high glucose in GK islets. The decrease in ROS production by
exendin-4 was not affected by H-89, a PKA inhibitor, and an
Epac-speciﬁc cAMP analog (8CPT-2Me-cAMP) signiﬁcantly de-
creased Src Tyr416 phosphorylation and ROS production.
CONCLUSIONS—Exendin-4 decreases endogenous ROS pro-
duction and increases ATP production in diabetic GK rat islets
through suppression of Src activation, dependently on Epac.
Diabetes 60:218–226, 2011
I
n pancreatic -cells, glucose metabolism regulates
exocytosis of insulin granules through metabolism
secretion coupling, in which glucose-induced ATP
production in mitochondria plays an essential role
(1). Impairment of mitochondrial ATP production causes
reduced glucose-induced insulin secretion.
Reactive oxygen species (ROS) is one of the most
important factors that impair metabolism secretion cou-
pling in -cells. Exposure to exogenous hydrogen perox-
ide (H2O2), the most abundant ROS, reduces glucose-
induced insulin secretion by impairing mitochondrial
metabolism in -cells (2,3). However, little is known of the
role of endogenous ROS in impaired glucose-induced
insulin secretion from -cells. Some studies (4,5) have
shown that endogenous ROS is produced in mitochondria
by exposure to high glucose. In Zucker diabetic fatty rats,
the superoxide content of islets at basal glucose levels is
higher than that in Zucker lean control rats (4). Further-
more, we recently reported that high glucose–induced
ROS production in islet cells is elevated in diabetic Goto-
Kakizaki (GK) rats compared with control Wistar rats (6).
Thus, endogenous ROS production is elevated in -cells
under diabetic pathophysiological conditions.
Although the mechanism of endogenous ROS produc-
tion in -cells in the diabetic state remains largely un-
known, we have reported that Src (c-Src) plays an
important role in the signal transduction that produces
ROS (6). Src is a nonreceptor tyrosine kinase that is
associated with the cell membrane and plays important
roles in various signal transductions, and its activity is
regulated by intramolecular interactions that depend on
tyrosine phosphorylation (7,8). Phosphorylation of Tyr527
(Tyr529 in humans), which is located near the C terminus
of Src, is brought about by COOH terminal Src kinase
(Csk), a negative regulator of Src (9), and holds the kinase
in the inactive form. Dephosphorylation of Tyr527 fol-
lowed by disruption of the intramolecular interaction
allows phosphorylation of Tyr416 (Tyr418 in humans) at
the kinase domain, resulting in Src activation. In our
previous report (6), PP2, a selective Src inhibitor, de-
creased high-glucose–induced ROS production in GK islet
cells, in contrast to the lack of any effect of the agent in
Wistar islet cells, suggesting that Src may be activated in
the diabetic condition and cause elevation of ROS produc-
tion in the presence of high glucose.
Glucagon-like peptide (GLP)-1 is one of the incretin
peptides released from the intestine in response to nutri-
ent ingestion that augments glucose-induced insulin secre-
tion from -cells (10,11). GLP-1 binding to the GLP-1
receptor, a member of the G protein–coupled receptor
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clase and elevation of intracellular cAMP levels, which
elicits protein kinase A (PKA)-dependent signal transduc-
tion. Recently, Epac (also known as cAMP-GEF [guanine
nucleotide exchange factor]) has been shown to be a novel
cAMP sensor in the PKA-independent pathway (12,13). In
-cells, one member of the Epac family, Epac2, has an
important role in insulin secretion, especially in regulation
of exocytosis of insulin granules (14,15). Previous studies
have shown that GLP-1 also has beneﬁcial long-term
effects on diabetic -cells, including induction of -cell
proliferation (16,17), enhanced resistance to apoptosis
(17,18), and amelioration of endoplasmic reticulum stress
(19). Furthermore, increased ROS in diabetic db/db mouse
islets is decreased by treatment with an inhibitor of
dipeptidyl peptidase IV that delays the degradation of
GLP-1 (20).
In the present study, we investigated whether the GLP-1
signal directly ameliorates endogenous ROS production in
diabetic GK islets using exendin-4, a GLP-1 receptor
agonist. In particular, we focused on clarifying regulation
of Src activity by GLP-1 signaling. We describe here both a
novel effect and a mechanism of GLP-1 signaling that
acutely decreases ROS production by high glucose
through suppression of Src activation PKA independently
and Epac dependently.
RESEARCH DESIGN AND METHODS
Male Wistar and GK rats were obtained from Shimizu (Kyoto, Japan). All
experiments were carried out with rats that were aged 7–8 weeks. Nonfast-
ing blood glucose levels were 160–240 mg/dl in the GK rats and 70–120
mg/dl in the Wistar rats used in the experiments. The animals were maintained
and used in accordance with the guidelines of the animal care committee of
Kyoto University.
Islet preparation. Pancreatic islets were isolated from Wistar and GK rats by
the collagenase digestion technique (6). Isolated islets were washed with
Krebs Ringer bicarbonate buffer (KRBB) (in mmol/l: 129.4 NaCl, 5.2 KCl, 2.7
CaCl2, 1.3 KH2PO4, 1.3 MgSO4, and 24.8 NaHCO3 [equilibrated with 5%
CO2/95% O2, pH 7.4]) containing 2.8 mmol/l glucose and cultured for 2 0hi n
RPMI-1640 medium containing 5.5 mmol/l glucose and 10% FCS. Cultured
islets were preincubated for 30 min at 37°C in KRBB supplemented with 0.2%
BSA and 10 mmol/l HEPES (KRBB medium) containing 2.8 mmol/l glucose
and incubated for the indicated times at 37°C in KRBB medium containing
16.7 mmol/l glucose with or without test materials.
Retroviral-mediated gene transfer. Production of retroviral vectors with
pCX4 was performed as previously described (21). Src kinase–negative
mutant (K295M) was subcloned into pCX4pur (22). Gene transfer experiments
of islets were carried out by an in vivo gene transduction method (23). Brieﬂy,
after rats were anesthetized and subjected to laparotomy, the hepatic artery
with the portal vein and the splenic artery were ligated. The upper side of the
celiac artery that branches from the abdominal aorta was clamped, and 100 l
of retroviral vector suspension was injected into the lower side of the clamped
point of the artery. The pancreatic islets were then isolated and cultured for
48 h before the experiment. Gene expression using green ﬂuorescent protein–
expressing vector was effective in the inside of the islets, as previously
reported (23).
Immunoprecipitation and immunoblotting. Fresh or incubated islets were
lysed in ice-cold lysis buffer (10 mmol/l Tris [pH 7.2], 100 mmol/l NaCl, 1
mmol/l EDTA, 1% Nonidet P-40, and 0.5% sodium deoxycholate) containing
protease inhibitor cocktail (Complete; Roche, Mannheim, Germany), phospha-
tase inhibitor cocktail (Calbiochem, Darmstadt, Germany), and 5 mmol/l
sodium pyrophosphate. For determination of Src activation, lysates were
centrifuged at 560,000g for 10 min at 4°C, and the supernatant (2m go f
protein content/2,500 islets) was mixed with 4 g mouse monoclonal anti-Src
antibody (clone GD11; Upstate, Billerica, MA) and 30 l washed protein G
Sepharose (GE Healthcare, Uppsala, Sweden) followed by gentle rotation for
4 h at 4°C. Immunoprecipitates or islet lysates (50 g) were subjected to
immunoblotting as previously described (23). Primary antibodies used were
rabbit anti–phospho-Src (Tyr416) and anti–phospho-Src (Tyr527) from Bio-
source (Camarillo, CA); rabbit anti-Src, anti-Csk, anti-Epac2, extracellular
signal–regulated kinase (ERK) 1/2, and mouse anti–phospho-ERK1/2 (Thr202/
Tyr204) from Santa Cruz Biotechnology (Santa Cruz, CA); rabbit anti-Rap1
from Upstate; rabbit anti–phospho-Akt (Ser473) and anti-Akt from Cell
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FIG. 1. Comparison of expression of Src between fresh Wistar and GK islets. Fresh islets were lysated and subjected to immunoblot analyses.
Blots (50 g of protein) were probed with anti–phospho-Src (Tyr
416), anti–phospho-Src (Tyr
527), anti-Src, or anti-Csk. The same blots were
stripped and reprobed with anti–-actin, respectively. Intensities of the bands were quantiﬁed with densitometric imager. The bar graphs are
expressed relative to Wistar islet value corrected by -actin level (means  SE). *P < 0.05; †P < 0.01; ‡P < 0.001. Representative blot panels of
three to ﬁve independent experiments are shown.
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Secondary antibodies used were horseradish peroxidase–conjugated anti-
rabbit and mouse antibody (GE Healthcare). Band intensities were quantiﬁed
with Multi Gauge software (Fujiﬁlm, Tokyo, Japan).
Measurement of ROS production. ROS production in islet cells was
measured by 2,7-dichloroﬂuorescein ﬂuorescence (6). Brieﬂy, cultured islets
were dispersed using 0.05% trypsin/0.53 mmol/l EDTA (Invitrogen, Carlsbad,
CA) and PBS. Dispersed islet cells were preincubated in KRBB medium
containing 2.8 mmol/l glucose and 10 mol/l 5-(and 6-) chloromethyl-2,7-
dichlorodihydroﬂuorescein diacetate (CM-H2DCFDA; Invitrogen) for 20 min at
37°C. After a 60-min incubation in 400 l KRBB medium containing 16.7
mmol/l glucose with or without test materials, ﬂuorescence was measured
using a spectroﬂuorophotometer (RF-5300PC; Shimadzu, Kyoto, Japan), with
excitation wavelength at 505 nm and emission wavelength at 540 nm.
Fluorescence was corrected by subtracting parallel blanks and represented by
fold increases of the value at time zero.
Measurement of ATP content. ATP content in islets was determined by
luminometry as previously described (6). Brieﬂy, after preincubation, groups
of 10 islets were batch incubated for 30 min in KRBB medium containing 2.8
or 16.7 mmol/l glucose with or without test materials. Incubation was stopped
immediately by addition of HClO4 and sonication in ice-cold water for 10 min.
They were then centrifuged, and a fraction of the supernatant was mixed with
HEPES and Na2CO3. The ATP content in the supernatant of islet lysates was
measured using ENLITEN luciferase/luciferin reagent (Promega, Madison,
WI) with a luminometer (GloMax 20/20n; Promega).
Materials. Exendin-4 and forskolin were purchased from Sigma. PP2 was
purchased from Tocris (Ellisville, MO). PP3, H-89, myristoylated PKA inhibitor
amide14–22 (PKI), LY294002, wortmannin, PD98059, and AG1478 were pur-
chased from Calbiochem. Dibutyryl cAMP was purchased from Daiichisankyo
(Tokyo, Japan). 8-(4-chlorophenylthio)-2-O-methyl-cAMP (8CPT-2Me-cAMP)
was purchased from Biolog Life Science (Bremen, Germany).
Statistical analysis. Data are expressed as means  SE. Statistical signiﬁ-
cance of difference was evaluated by the unpaired Student t test. P  0.05 was
considered signiﬁcant.
RESULTS
Comparison of expression of Src between Wistar and
GK islets. To examine whether the expression levels of
Src in GK islets differ from those in Wistar islets, immu-
noblotting using fresh islets was performed. As shown in
Fig. 1A, the level of Src pY416, which indicates activation
of Src, in GK islets was signiﬁcantly higher than that in
Wistar islets. The levels of Src pY527, total Src, and Csk
in GK islets were signiﬁcantly lower than those in Wistar
islets. The levels of other Src family kinases (SFKs) were
similar in Wistar and GK islets, whereas the expression of
Fgr was very low and that of Fyn was undetectable
(supplementary Fig. 1 in the online appendix, available
at http://diabetes.diabetesjournals.org/cgi/content/full/
db10-0021/DC1). Results of immunoblotting using islets
cultured for 20 h in the presence of 5.5 mmol/l glucose
(supplementary Fig. 2) were similar to those shown in
Fig. 1A.
Exendin-4 suppresses Src activity in GK islets. To
investigate whether exendin-4 regulates Src activity, phos-
phorylation of Src was examined by immunoprecipitation
and immunoblotting. As shown in Fig. 2A, Src pY416 was
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FIG. 2. Exendin-4 suppresses Src activity at high glucose in GK islets. Effects of exendin-4 on Src activity at high glucose in GK (A) and Wistar
(B) islets. After preincubation in the presence of 2.8 mmol/l glucose for 30 min, islets were incubated in the presence of 16.7 mmol/l glucose with
or without 100 nmol/l exendin-4 for 10 min. Islet lysates (2 mg of protein) were immunoprecipitated with anti-Src antibody and subjected to
immunoblot analyses. Blots were probed with anti–phospho-Src (Tyr
416), anti–phospho-Src (Tyr
527), or anti-Src by stripping and reprobing of the
same blots. Intensities of the bands were quantiﬁed with densitometric imager. The bar graphs are expressed relative to control value corrected
by Src level (means  SE). *P < 0.05; †P < 0.01. Representative blot panels of four (A) or three (B) independent experiments are shown.
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presence of 16.7 mmol/l glucose in GK islets. Exendin-4
also signiﬁcantly increased Src pY527 in GK islets in the
same condition. On the other hand, exendin-4 did not
affect Src pY416 or pY527 at high glucose in Wistar islets
(Fig. 2B). Both Src pY416 and pY527 were not altered by
change in glucose concentration in GK or Wistar islets
(supplementary Fig. 3).
Exendin-4 decreases ROS production in GK islet
cells. We then investigated whether exendin-4 ameliorates
endogenous ROS production at high glucose in GK islet
cells. A total of 16.7 mmol/l glucose exposure induced ROS
production in GK islet cells (Fig. 3A). Coexposure of
exendin-4 signiﬁcantly decreased ROS production in the
presence of 16.7 mmol/l glucose at 15, 30, and 60 min. A
total of 10 mol/l PP2, a Src inhibitor, signiﬁcantly de-
0 
1.0 
2.0 
3.0 
4.0 
0  15 30 45  60 
Time (min) 
C
M
-
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
s
)
 
0 
1.0 
2.0 
3.0 
4.0 
Control Ex  Fors 
C
M
-
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
s
)
 
* 
† 
A 
C  D 
0 
1.0 
2.0 
3.0 
4.0 
C
M
-
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
s
)
 
Control Ex  Fors 
Ex 
control 
* 
* 
* 
0 
1.0 
2.0 
3.0 
4.0 
Mock 
C
M
-
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
s
)
 
Src-KN 
‡  F 
B 
0 
1.0 
2.0 
3.0 
4.0 
Control Ex  PP2  Ex+PP2 
C
M
-
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
s
)
  * 
* 
ns 
Control 
C
M
-
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
s
)
 
PP3 
E 
0 
1.0 
2.0 
3.0 
4.0 
FIG. 3. Exendin-4 decreases ROS production at high glucose in GK islet cells. A: Time course of high-glucose–induced ROS production with or
without 100 nmol/l exendin-4 in GK islet cells. After preincubation in the presence of 2.8 mmol/l glucose and 10 mol/l CM-H2DCFDA for 20 min,
dispersed islet cells were incubated in the presence of 16.7 mmol/l glucose with (F) or without (E) 100 nmol/l exedin-4 for 60 min. Fluorescence
is represented as fold increases against the value at time zero. Data are expressed as means  SE (n  5–7). *P < 0.05 vs. control. B: Effects of
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Src-KN vector)-mediated gene transfer to islets was carried out by in vivo gene transduction method, as described in RESEARCH DESIGN AND METHODS.
Data are expressed as means  SE (n  3). ‡P < 0.001.
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but PP3, the inactive PP2 analog, did not affect it (Fig. 3E).
Exendin-4 did not further decrease ROS production in the
presence of PP2 (Fig. 3B), suggesting that the effect of
exendin-4 is via the Src signal. The decrease in high-
glucose–induced ROS production also was observed in the
presence of 10 mol/l forskolin, an adenylyl cyclase acti-
vator (Fig. 3C). High-glucose–induced ROS production in
Wistar islet cells was lower than that in GK islet cells and
was not changed by addition of exendin-4 or forskolin
(Fig. 3D). To conﬁrm that Src is actually involved in ROS
production, we measured ROS production in GK islets
expressing a kinase-negative form of Src (Src-KN) by
retroviral vector. ROS production in Src-KN–expressing
islets was signiﬁcantly lower than that in control (Fig. 3F),
demonstrating that Src regulates ROS production in GK
islets.
Exendin-4 increases ATP content in GK islets. In
Wistar islets, 16.7 mmol/l glucose-exposure signiﬁcantly
increased ATP content compared with that in the presence
of 2.8 mmol/l glucose, as shown in Fig. 4B. Exendin-4, PP2,
or exendin-4 plus PP2 did not affect the ATP content in the
presence of 16.7 mmol/l glucose in Wistar islets. The ATP
content in GK islets exposed to 16.7 mmol/l glucose was
not increased compared with that in the presence of 2.8
mmol/l glucose (Fig. 4A). Exendin-4 as well as PP2 signif-
icantly increased the ATP content in the presence of 16.7
mmol/l glucose. Further increase of ATP content by com-
bined exendin-4 and PP2 was not observed.
The effects of exendin-4 are dependent on Epac. We
then investigated whether the decrease in ROS production
by exendin-4 is dependent on PKA. As shown in Fig. 5A,
decreased ROS production by exendin-4 or forskolin was
not affected by 10 mol/l H-89 or PKI, a PKA inhibitor,
indicating that the effect is PKA independent. Not only
dibutyryl cAMP, a general cAMP analog, but also 8CPT-
2Me-cAMP, an Epac-speciﬁc cAMP analog, decreased ROS
production (Fig. 5C). Epac possesses guanine nucleotide
exchange factor activity toward Rap1, a member of the
Ras superfamily of small GTPases. Epac2 and Rap1 pro-
teins were expressed similarly in both Wistar and GK islets
(Fig. 5B). To determine involvement of Epac in Src acti-
vation, Src phosphorylation was examined. Src pY416 was
signiﬁcantly decreased by 8CPT-2Me-cAMP (Fig. 5D).
A downstream pathway of Src is PI3K/Akt signaling.
Src signalings toward downstream proteins are complex,
but one of the typical pathways is phosphatidylinositol 3
kinase (PI3K)/Akt signaling (8). We therefore examined
the involvement of PI3K/Akt signaling on ROS production.
A total of 50 mol/l LY294002 and 0.5 mol/l wortmannin,
both of which are PI3K inhibitors, signiﬁcantly decreased
ROS production in GK islets (Fig. 6A). Exendin-4 and PP2
both signiﬁcantly decreased phosphorylation of Akt in GK
islets (Fig. 6B) but not in Wistar islets (Fig. 6C). Consid-
ering these ﬁndings together, PI3K/Akt signaling that pro-
duces ROS is located downstream of Src activation. We
also examined the involvement of mitogen-activated pro-
tein kinase signaling, another downstream pathway of Src.
A total of 50 mol/l PD98059, a MAPK-ERK kinase inhib-
itor, did not affect ROS production in GK islets (Fig. 6D),
and neither exendin-4 nor PP2 affected phosphorylation of
ERK (Fig. 6E). Several GPCR agonists have been shown to
induce transactivation of epidermal growth factor recep-
tor (EGFR) (24,25) by a mechanism involving Src (25–27)
and frequently subsequent PI3K/Akt signaling (25,28).
Therefore, involvement of EGFR transactivation on regu-
lation of ROS production was examined. A total of 0.5
mol/l AG1478, an EGFR kinase inhibitor, signiﬁcantly
decreased ROS production (Fig. 6F).
DISCUSSION
We previously reported that endogenous ROS production
by high glucose in diabetic GK islets is elevated compared
with that in control Wistar islets and is effectively amelio-
rated by Src inhibition, suggesting that Src may be acti-
vated in GK islets (6). In the present study, we ﬁrst
investigated whether Src activity is altered in GK islets.
Immunoblotting analysis revealed that the level of Src
pY416, which indicates the level of Src activation, is higher
in GK islets than that in Wistar islets, despite lower levels
of total Src, Src pY527, and Csk. The lower level of total
Src seems to be a consequence of Src activation. Targeted
degradation of active forms of Src is brought about by
ubiquitination (29). The protooncogene c-Cbl, recently
found to be an E3 ubiquitin ligase, mediates ubiquitination
of activated Src (30). These reports suggest that increased
degradation of activated Src may result in a lower level of
total Src in GK islets. In addition, a lower level of Csk
might cause a lower activity of the kinase in GK islets.
However, Src activity is not directly regulated through
phosphorylation of Tyr527 by Csk (8), and a subtle de-
crease in Csk activity is not believed to contribute to
regulation of Src activity because of the excess amount of
expression of Csk. This is supported by the ﬁndings that
heterozygous disruption of ubiquitously expressed Csk
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tube defects and embryonic lethality in homozygous deﬁ-
cient mice (31). Moreover, the localization of Csk in the
cytosol before recruitment to the membrane for Src regu-
lation dose not differ in Wistar and GK islets (supplemen-
tary Fig. 4). Thus, the lower expression level of Csk found
in our results is not likely to play a role in the Src
activation in GK islets. Activation of Src as well as elevated
endogenous ROS production at high glucose in GK islets
was clearly suppressed by exendin-4, which did not affect
Src phosphorylation or ROS production in Wistar islets.
Thus, the GLP-1 signal might well suppress activation of
Src and excessive ROS production under diabetic condi-
tions in addition to other beneﬁcial long-term effects on
-cells.
GLP-1 induces elevation of intracellular cAMP levels
and subsequent activation of PKA after binding to the
GLP-1 receptor. In the present study, the effect of GLP-1
signaling, which suppresses Src activation and ROS pro-
duction, was found to be independent of PKA. Epac is a
PKA-independent cAMP sensor; Epac2 is expressed
mainly in neuroendocrine cells including pancreatic
-cells. Epac2 regulates exocytosis of insulin granules in
-cells by mobilizing intracellular Ca
2 and interacting
granule-associated proteins (14,15). Although the relation-
ship between Epac and Src is not well known, a recent
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cyte apoptosis Epac dependently through Src and PI3K/
Akt activation. Further evaluation of the role of cAMP in
regulation of Src and PI3K/Akt signaling is required.
In the present study, we have shown that one of these
Src signals, the PI3K/Akt signal, regulates ROS production.
Furthermore, GLP-1 induces -cell proliferation through
PI3K signaling via Src and EGFR transactivation (33). Our
ﬁnding that the EGFR kinase inhibitor decreases ROS
production suggests that EGFR transactivation may be
involved in the ROS-reducing effect of exendin-4 via Src.
Under normal conditions, GPCR stimulation generally
activates Src toward EGFR transactivation, frequently
followed by PI3K activation (25). The present study re-
veals that Src and PI3K activities are upregulated in islets
under diabetic conditions, which are suppressed by the
GLP-1 signal. Many studies in oncology have shown that
several growth factors including EGF and platelet-derived
growth factor induce ROS through PI3K activation (34–
36). Thus, EGFR transactivation/PI3K signaling should be
activated under pathophysiologically disordered condi-
tions. In the various states between normal and diabetic
conditions, the ameliorative effects of the GLP-1 signal
may differ (37). Further elucidation of these signals in the
pathophysiology of diabetes should be helpful in future
development of therapeutic strategies.
Previous studies have shown that the antioxidant capac-
ity in -cells is very low because of weak expression of
antioxidant enzymes in pancreatic islets compared with
that in various other tissues (38). The superoxide anion is
converted by superoxide dismutase (SOD) into hydrogen
peroxide that is eventually removed by glutathione perox-
idase (Gpx). The expression level of MnSOD, which is
localized in mitochondria, was signiﬁcantly lower in GK
islets than in Wistar islets, and that of of Gpx was similar
in Wistar and GK islets (supplementaty Fig. 5A). However,
an enzymatic assay revealed that MnSOD activity in GK
islets was similar to that in Wistar islets and that it was not
affected by exendin-4 or PP2 (supplementary Fig. 5B and
C). These results indicate that regulation of MnSOD activ-
ity does not play a role in the suppressive effects of ROS
production by exendin-4.
One of the important sites of ROS generation in -cells is
the mitochondrial electron transport chain, in which ROS
generation increases according to the hyperpolarization of
mitochondrial inner membrane derived from accelerated
glucose metabolism (39). However, in pathophysiological
conditions, NADPH oxidase may play an important role in
ROS generation in -cells. Chronic exposure to proinﬂamma-
tory cytokines and abundant nutrients including glucose and
palmitate augments the expression of a phagocyte-like
NADPH oxidase in -cells (40). Moreover, the expression of
NADPH oxidase is increased in islets of diabetic Otsuka Long
Evans Tokushima Fatty rats (41). Because Src is involved in
regulation of NADPH oxidase activity (42), further examina-
tion to elucidate the site of ROS generation related to Src
activation in -cells is needed. On the other hand, previous
reports have shown that ROS itself regulates Src activity
(43,44) in addition to Src activity regulation of ROS produc-
tion (45). To clarify this mutual causal relationship between
Src and ROS, we examined ROS production in GK islets
expressing Src-KN, which was found to cause a distinct
decrease in high-glucose–induced ROS production. This ﬁnd-
ing demonstrates that Src activity regulates ROS production
and does not contradict the possibility of a feedback regula-
tion mechanism of ROS on Src activity (45).
The high-glucose–induced increase in ATP production is
impaired in GK rats (6,46) as well as in patients with type
2 diabetes (47). In addition, islets in GK rats and human
type 2 diabetes are oxidatively stressed (48–50). In the
present study, exendin-4 was able to recover this impaired
increase in ATP production by high glucose in GK islets as
well as to decrease excessive ROS production. Thus,
GLP-1 signaling may improve -cell function in the dia-
betic state not only because it enhances Ca
2 efﬁcacy of
the exocytotic system of insulin granules but also because
it improves impaired metabolism-secretion coupling.
GLP-1 receptor agonists are widely used in treatment of
type 2 diabetes for their ability to improve glucose intol-
erance. Their clinical beneﬁcial effect seems to be pro-
vided not only by their insulinotropic action but also by
their reduction of -cell apoptosis and induction of -cell
proliferation (16–18). Further elucidation of endogenous
ROS regulation by GLP-1 may help to clarify the mecha-
nism of the various beneﬁcial effects of these agents.
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EXENDIN-4 SUPPRESSES ROS IN GK ISLET VIA Src
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